Tag: China

In China Approved Home-grown Vaccines

According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers’ products. According to a notice released by China’s National Medical ...

Boehringer Ingelheim Manufactured First Biopharmaceutical Approved in China

boehringer
Through its collaboration with BeiGene, Ltd. and the provision of manufacturing services for their monoclonal antibody tislelizumab, Boehringer Ingelheim Biopharmaceuticals China is the first company ...

National Vaccine Tracking System in China to be Completed Before 31 March 2020

A national vaccine tracking system in China will aim to be completed before 31 March 2020, a report has said. China will aim to complete a national vaccine tracking system before 31 March 202...

Astellas Got XTANDI Approval in China

astellas
Astellas Pharma Inc. announced that the China National Medical Products Administration (NMPA) approved a new drug application (NDA) for XTANDI® (enzalutamide) on November 18 for the treatment of adult...

Chinese Authorities Accept Chi-Med Application for Surufatinib

china street
Hutchison China MediTech Limited announces that its New Drug Application for surufatinib for the treatment of patients with advanced non-pancreatic neuroendocrine tumors has been accepted for review b...

AstraZeneca Launches Large-Scale Initiatives in China for Global Medicine R&D Advancement

astrazeneca
AstraZeneca announced three large-scale initiatives to build on the Company’s long-standing commitment to China and advance global research and development (R&D) for innovative new medicines. T...

Shanghai Green Valley Secured Conditional Approval for GV-971

Chinese pharmaceutical firm Shanghai Green Valley Pharmaceuticals has secured conditional approval from the country’s regulatory agency for Oligomannate (GV-971) to improve cognitive function in mild ...

Amgen Entered into Strategic Collaboration with BeiGene

amgen
Amgen announced that it has entered into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand its oncology presence in China, the world's second-largest ph...

European and Chinese Authorities Talked on Medicine Regulation

European-Commission
The Deputy Commissioner of the Chinese National Medical Product Administration (NMPA), Dr. Chen Shifei, visited EMA on 25 October together with a delegation.  The visit took place in the context of...

Merck’s KEYTRUDA Approved by NMPA in China

Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NMPA) in China as monot...

Eisai and Nichi-Iko Entered Collaboration Agreement for Generics in China

generic
Eisai Co., Ltd. and Nichi-Iko Pharmaceutical announced that they have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China. The Chinese pharmaceutic...

BIOCAD and Shanghai Pharma Agreed to Establish Joint Venture in China

biocad
BIOCAD and Shanghai Pharma Holding finalized the deal to establish a joint venture in China. On September the 17th, during a ceremony in Constantine’s Palace, Russian Prime Minister Dmitry Me...

Seven Pharma Companies Won Bids in China’s Expanded Government Procurement Scheme

china
Good news for multinational drugmakers - or better-than-expected news, that is. After bracing for China’s expanded government procurement scheme and the price cuts destined to come with it, the countr...

Biocon Signed Agreement with Subsidiary of CMS for Three Generic Formulation Products

biocon
Biocon Ltd, Asia’s premier biopharmaceuticals company, announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formu...

AZ Received Approval for Tagrisso in China

AstraZeneca has scored another approval for one of its new drugs in China, this time getting a green light for Tagrisso as a first-line treatment for adults with EGFR-positive non-small cell lung canc...

Discussion on Prospects of Russian-Chinese Cooperation in Biopharmaceutics Was Held at SID&GP

The Department of Pharmaceutical and Medical Industry Development of the Ministry of Industry and Trade of the Russian Federation and the State Institute of Drugs and Good Practices (SID&GP) have ...